ImmunitasBio Pvt Ltd.

Immunohistochemistry (IHC) is a lab technique that uses #antibodies to detect #antigens in tissue samples to help diagnose disease, predict treatment response, and determine prognosis. IHC is a combination of #histology and #immunology that allows #pathologists to identify the presence and location of antigens in cells. Here are some basics of IHC: 🟢 Purpose IHC is used to identify proteins linked to #diseases, confirm the presence of infectious agents, and classify cells and determine their organ of origin. 🟢 Process: The IHC process involves collecting tissue specimens, fixing them, sectioning them, and then performing staining steps. The staining steps include antigen retrieval, adding a primary antibody, applying a secondary antibody, and adding a #detection #reagent. 🟢 Visualizing the interaction: To visualize the interaction between the antigen and antibody under a microscope, either the primary or secondary antibody must be labeled. 🟢 Double staining Pathologists can use specific #chromogens in the same #tissuesection to visualize two antigens on one slide. This is known as double staining. 🟢 Preserving histologic architecture: IHC preserves the histologic architecture of the tissue, allowing pathologists to assess the expression pattern of a molecule in the context of its #microenvironment. Follow ImmunitasBio Pvt Ltd. #linkedinpage for more interesting facts!

May this festival of lights fight all darkness out of your life.... ...like the immune system fights the foreign invaders out of our body. ImmunitasBio wishes a prosperous and Happy Diwali to one and all!

Exploring Precision in Cell Analysis with Flow Cytometry 🔬 Flow Cytometry allows us to rapidly analyze individual cells, measuring specific biomarkers within diverse cell populations. At ImmunitasBio, we leverage the advanced Beckman Coulter CytoFlex LX platform in our immunoassay facilities, enabling us to capture detailed insights that drive our research forward. This technology is instrumental in identifying and analyzing cellular characteristics with high accuracy, supporting our mission to develop innovative #diagnostics. #cellanalysis #flowcytometry #immunoassays #biotech

We had a delightful experience at the American Association of Pharmaceutical Scientists (AAPS) | @aapscomms #PharmSci360 2024! Our CEO and Co-founder, Dr Shiv Baalasubramanian, presented our Whole Blood T-cell Test Platform in front of an august audience. We at ImmunitasBio Pvt Ltd., are grateful to the organisers for the opportunity. A special thanks to Vibha Jawa PhD FAAPS, the Executive Director and Yanshan Dai, the Senior Principal Scientist at Bristol Myers Squibb, for their support.

ImmunitasBio's T cell platform offers a versatile solution for measuring antigen-specific T cell responses. It is designed to be adaptable for resource-limited settings, eliminating the need for complex sample preparation and cold chain transport. The platform integrates with routine #bloodtests, can be expanded for various conditions, aids in patient selection and therapy monitoring, and has potential as a #diagnostic tool for specific diseases To discover more, please contact us at +91-8904711371 or write to us at info@immunitasbio.com ImmunitasBio Pvt Ltd Bangalore Bioinnovation Centre, Biotech Park, IBAB Campus Electronic city phase-1, Bangalore-560100 Karnataka, India

Only 3 days to go! Join ImmunitasBio Pvt Ltd. at the American Association of Pharmaceutical Scientists (AAPS) | @aapscomms #PharmSci360 2024! Our CEO, Dr Shiv Baalasubramanian, will share insights on " Low Blood Volume Alternative to Monitor Antigen-Specific Cellular Immune Responses". Join the session on Tuesday, October 22, 2024 10:00 AM – 10:30 AM MT Location: 151 ABCG, SALT PALACE CONVENTION CENTRE, Salt Lake City, UT

The Essential Role of T Cells in Long-Lasting Immune Protection New research highlights the crucial role of T cells in #immuneresponse, from #vaccination to long-term protection: ✅ After Vaccination: Strong T cell and memory B cell (MBC) responses provide a robust defence, supporting #antibody production and enhancing immune memory. ✅ Booster Impact: While #booster doses increase antibody levels, T cells and MBCs offer stable, long-term protection without requiring additional boosting. ✅ Hybrid Immunity: Individuals with prior #infection and vaccination exhibit the strongest T cell responses, leading to superior protection. ✅ Long-Term Immunity: T cells maintain defence over time, reducing the risk of severe disease even as antibody levels naturally decrease. Innovative T Cell Platform by ImmunitasBio ImmunitasBio has developed a cutting-edge platform to measure antigen-specific T-cells, providing a more precise and effective way to monitor #immuneresponses. This platform allows researchers to assess T-cell function with higher accuracy, helping improve #disease #diagnostics and #treatment strategies. T Cells are key to durable immunity—track their activity with advanced solutions from ImmunitasBio.

Current limitations in assessing antigen-specific cellular immune responses hinder fast-paced diagnostics. At ImmunitasBio Pvt Ltd., we developed a novel platform to tackle these challenges. Join our CEO and Co-Founder, Dr Shiv Baalasubramanian, at the American Association of Pharmaceutical Scientists (AAPS) | @aapscomms on October 22 at #PharmSci 2024. Here are a few takeaways from his session on "Low Blood Volume Alternative to Monitor Antigen-Specific Cellular Immune Responses": Learning Objectives: ✅ Learn about a less expensive alternative method to evaluate antigen-specific T-cell immune response ✅ Learn about the current limitations of existing methods for measuring T cell immune response ✅ Learn about the versatile test platform as it can be adopted for many other antigens and disease conditions. ✅ Learn how the test can be a valuable tool for large-scale population studies

Why studying cellular and humoral immunity is critical in #diseasemonitoring? Studying both cellular and #humoralimmunity provides deeper insights into disease progression, severity, and #patient outcomes. This knowledge helps refine #vaccines and treatments, ultimately saving lives. Follow us on #linkedin for more interesting insights!

We are excited to announce our participation in the American Association of Pharmaceutical Scientists (AAPS) | @aapscomms #PharmSci360 2024! Our CEO, Dr. Shiv Baalasubramanian, will share insights on " Low Blood Volume Alternative to Monitor Antigen-Specific Cellular Immune Responses". Join the session on Tuesday, October 22, 2024 10:00 AM – 10:30 AM MT Location: 151 ABCG, SALT PALACE CONVENTION CENTRE, Salt Lake City, UT